Menu
GeneBe

rs868118584

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_017890.5(VPS13B):c.11014G>A(p.Ala3672Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000136 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A3672A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

VPS13B
NM_017890.5 missense

Scores

5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 5.65
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VPS13BNM_017890.5 linkuse as main transcriptc.11014G>A p.Ala3672Thr missense_variant 57/62 ENST00000358544.7
VPS13BNM_152564.5 linkuse as main transcriptc.10939G>A p.Ala3647Thr missense_variant 57/62 ENST00000357162.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VPS13BENST00000358544.7 linkuse as main transcriptc.11014G>A p.Ala3672Thr missense_variant 57/621 NM_017890.5 Q7Z7G8-1
VPS13BENST00000357162.7 linkuse as main transcriptc.10939G>A p.Ala3647Thr missense_variant 57/621 NM_152564.5 P1Q7Z7G8-2

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152096
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000398
AC:
1
AN:
251462
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000103
AC:
15
AN:
1461834
Hom.:
0
Cov.:
32
AF XY:
0.00000963
AC XY:
7
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000899
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152096
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000831

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cohen syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingInvitaeSep 19, 2022This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3672 of the VPS13B protein (p.Ala3672Thr). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 576857). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VPS13B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Mar 13, 2020- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 26, 2021DNA sequence analysis of the VPS13 gene demonstrated a sequence change, c.11014G>A, in exon 57 that results in an amino acid change, p.Ala3672Thr. This sequence change has been described in the gnomAD database with a frequency of 0.004% in the African/African-American subpopulation (dbSNP rs868118584). The p.Ala3672Thr change affects a moderately conserved amino acid residue located in a domain of the VPS13B protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ala3672Thr substitution. This sequence change does not appear to have been previously described in individuals with VPS13B-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Ala3672Thr change remains unknown at this time. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 21, 2023The c.11014G>A (p.A3672T) alteration is located in exon 57 (coding exon 56) of the VPS13B gene. This alteration results from a G to A substitution at nucleotide position 11014, causing the alanine (A) at amino acid position 3672 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
VPS13B-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 31, 2023The VPS13B c.10939G>A variant is predicted to result in the amino acid substitution p.Ala3647Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-100871603-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.094
T
BayesDel_noAF
Benign
-0.29
Cadd
Benign
22
Dann
Uncertain
0.98
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.085
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.037
D
MetaRNN
Uncertain
0.51
D;D
MetaSVM
Benign
-0.94
T
MutationTaster
Benign
0.93
D;D;D
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.83
N;N
REVEL
Benign
0.10
Sift
Benign
0.44
T;T
Sift4G
Uncertain
0.035
D;D
Polyphen
0.78
P;P
Vest4
0.64
MutPred
0.33
.;Gain of sheet (P = 0.0827);
MVP
0.57
MPC
0.30
ClinPred
0.74
D
GERP RS
5.0
Varity_R
0.12
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs868118584; hg19: chr8-100871603; COSMIC: COSV100662212; API